A single-component research material supplied for controlled research environments. Suitable for studies involving GLP-1 receptor–related pathway characterization and method development in model systems.

GLP-1 receptor agonists (such as semaglutide and tirzepatide) are potent medications that mimic natural gut hormones to regulate blood sugar, significantly reduce appetite, and promote weight loss. Beyond weight loss, they offer significant benefits including reduced cardiovascular risk (heart attack/stroke), improved kidney function, lower blood pressure, fatty liver improvement (MASH), and reduced inflammation. 

Cleveland Clinic +3

• Significant Weight Loss: These drugs act on the brain to reduce cravings and "food noise" while slowing stomach emptying to increase fullness.
• Blood Sugar Management: Primarily used for Type 2 diabetes, they help the pancreas release insulin only when blood sugar levels are high.
• Cardiovascular Protection: Studies show up to a 20% reduction in major adverse cardiovascular events (MACE) in patients with obesity.
• Improved Liver & Kidney Health: GLP-1s show promise in treating Metabolic-Associated Steatohepatitis (MASH) and reducing complications from kidney disease.
• Reduced Inflammation: Emerging research suggests reduced inflammation in the brain and body, which may lower the risk of Alzheimer's and other neurocognitive disorders.
• Other Potential Benefits: These include improvements in sleep apnea and potential reduction in addictive behaviors. 
  WashU Medicine +6

Composition

• GLP-1 S
• Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Peptide identity and purity assessment via HPLC/LC-MS
• Assay development and calibration for quantitative analysis of GLP-1 receptor–related models
• Chromatographic method optimization for impurity profiling and peak resolution
• Stability characterization of a lyophilized peptide under laboratory storage conditions

For qualified research professionals and institutional laboratories. Not for human use.

Documentation & Quality Assurance

Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control. We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process. These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.

Important Notice

This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.

Quality & Manufacturing

All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.

We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.

All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.